Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies

Sven J van der Lee¹, Charlotte E Teunissen², René Pool³, Martin J Shipley⁴, Alexander Teumer⁵, Vincent Chouraki⁶, Debora Melo van Lent⁷, Juho Tynkkynen⁸, Krista Fischer⁹, Jussi Hernesniemi¹⁰, Toomas Haller⁹, Archana Singh-Manoux¹¹, Aswin Verhoeven¹², Gonneke Willemsen³, Francisca A de Leeuw¹³, Holger Wagner¹⁴, Jenny van Dongen³, Johannes Hertel¹⁵, Kathrin Budde¹⁶, Ko Willems van Dijk¹⁷, Leonie Weinhold¹⁸, M Arfan Ikram¹⁹, Maik Pietzner¹⁶, Markus Perola²⁰, Michael Wagner²¹, Nele Friedrich¹⁶, P Eline Slagboom²², Philip Scheltens²³, Qiong Yang²⁴, Robert E Gertzen²⁵, Sarah Egert²⁶, Shuo Li²⁴, Thomas Hankemeier²⁷, Catharina E M van Beijsterveldt³, Ramachandran S Vasan²⁸, Wolfgang Maier²¹, Carel F W Peeters²⁹, Hans Jörgen Grabe³⁰, Alfredo Ramirez³¹, Sudha Seshadri³², Andres Metspalu⁹, Mika Kivimäki⁴, Veikko Salomaa³³, Ayşe Demirkan³⁴, Dorret I Boomsma³, Wiesje M van der Flier³⁵, Najaf Amin¹, Cornelia M van Duijn³⁶

Affiliations

¹ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
² Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
³ Department of Biological Psychology, Vrije Universiteit Amsterdam, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands.
⁴ Research Department of Epidemiology and Public Health, University College London, London, UK.
⁵ Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
⁶ Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Labex Distalz, Lille, France.
⁷ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
⁸ University of Tampere, Tampere, Finland.
⁹ The Institute of Genomics, University of Tartu, Tartu, Estonia.
¹⁰ University of Tampere, Tampere, Finland; Heart Center, Tampere University Hospital, Tampere, Finland.
¹¹ Research Department of Epidemiology and Public Health, University College London, London, UK; Inserm U1018, Centre for Research in Epidemiology and Population Health, Villejuif, France.
¹² Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
¹³ Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands; Alzheimer Center & Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
¹⁴ Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
¹⁵ Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
¹⁶ Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
¹⁷ Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands.
¹⁸ Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.
¹⁹ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
²⁰ National Institute of Health and Welfare, Helsinki, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
²¹ German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
²² Section of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
²³ Alzheimer Center & Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
²⁴ Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
²⁵ Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
²⁶ Department of Nutrition and Food Sciences, Nutritional Physiology, University of Bonn, Bonn, Germany.
²⁷ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Faculty of Science, Universiteit Leiden, Leiden, The Netherlands; Translational Epidemiology, Faculty Science, Leiden University, Leiden, The Netherlands.
²⁸ Department of Medicine, Boston University School of Medicine, Boston, MA, USA; The Framingham Heart Study, Framingham, MA, USA.
²⁹ Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
³⁰ Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
³¹ Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany; Institute of Human Genetics, University of Bonn, Bonn, Germany; Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
³² Department of Neurology, Boston University School of Medicine, Boston, MA, USA; Glenn Biggs Institute of Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.
³³ National Institute of Health and Welfare, Helsinki, Finland.
³⁴ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
³⁵ Alzheimer Center & Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands; Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
³⁶ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Translational Epidemiology, Faculty Science, Leiden University, Leiden, The Netherlands. Electronic address: c.vanduijn@erasmusmc.nl.

PMID: 29316447
DOI: 10.1016/j.jalz.2017.11.012

Free article

Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies

Sven J van der Lee et al. Alzheimers Dement. 2018 Jun.

Free article

. 2018 Jun;14(6):707-722.

doi: 10.1016/j.jalz.2017.11.012. Epub 2018 Jan 6.

Authors

Affiliations

¹ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
² Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands.
³ Department of Biological Psychology, Vrije Universiteit Amsterdam, Neuroscience Campus Amsterdam, Amsterdam, The Netherlands.
⁴ Research Department of Epidemiology and Public Health, University College London, London, UK.
⁵ Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
⁶ Lille University, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE - Risk Factors and Molecular Determinants of Aging-Related Diseases, Labex Distalz, Lille, France.
⁷ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
⁸ University of Tampere, Tampere, Finland.
⁹ The Institute of Genomics, University of Tartu, Tartu, Estonia.
¹⁰ University of Tampere, Tampere, Finland; Heart Center, Tampere University Hospital, Tampere, Finland.
¹¹ Research Department of Epidemiology and Public Health, University College London, London, UK; Inserm U1018, Centre for Research in Epidemiology and Population Health, Villejuif, France.
¹² Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
¹³ Neurochemistry Laboratory and Biobank, Department of Clinical Chemistry, VU University Medical Center, Amsterdam Neuroscience, Amsterdam, The Netherlands; Alzheimer Center & Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
¹⁴ Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
¹⁵ Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
¹⁶ Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
¹⁷ Einthoven Laboratory for Experimental Vascular Medicine, Leiden University Medical Center, Leiden, The Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Endocrinology and Metabolic Diseases, Leiden University Medical Center, Leiden, The Netherlands.
¹⁸ Department of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.
¹⁹ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
²⁰ National Institute of Health and Welfare, Helsinki, Finland; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
²¹ German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
²² Section of Molecular Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
²³ Alzheimer Center & Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands.
²⁴ Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
²⁵ Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
²⁶ Department of Nutrition and Food Sciences, Nutritional Physiology, University of Bonn, Bonn, Germany.
²⁷ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Division of Analytical Biosciences, Leiden Academic Centre for Drug Research, Faculty of Science, Universiteit Leiden, Leiden, The Netherlands; Translational Epidemiology, Faculty Science, Leiden University, Leiden, The Netherlands.
²⁸ Department of Medicine, Boston University School of Medicine, Boston, MA, USA; The Framingham Heart Study, Framingham, MA, USA.
²⁹ Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
³⁰ Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Germany.
³¹ Department of Psychiatry and Psychotherapy, University of Bonn, Bonn, Germany; Department for Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany; Institute of Human Genetics, University of Bonn, Bonn, Germany; Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany.
³² Department of Neurology, Boston University School of Medicine, Boston, MA, USA; Glenn Biggs Institute of Alzheimer's and Neurodegenerative Diseases, University of Texas Health Sciences Center, San Antonio, TX, USA.
³³ National Institute of Health and Welfare, Helsinki, Finland.
³⁴ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
³⁵ Alzheimer Center & Department of Neurology, Amsterdam Neuroscience, VU University Medical Center, Amsterdam, The Netherlands; Department of Epidemiology & Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
³⁶ Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Translational Epidemiology, Faculty Science, Leiden University, Leiden, The Netherlands. Electronic address: c.vanduijn@erasmusmc.nl.

PMID: 29316447
DOI: 10.1016/j.jalz.2017.11.012

Erratum in

Erratum to "Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies" [Alzheimer's & Dementia 2018;14:707-22.].
[No authors listed] [No authors listed] Alzheimers Dement. 2019 Feb;15(2):319. doi: 10.1016/j.jalz.2019.01.002. Alzheimers Dement. 2019. PMID: 30736960 No abstract available.

Abstract

Introduction: Identifying circulating metabolites that are associated with cognition and dementia may improve our understanding of the pathogenesis of dementia and provide crucial readouts for preventive and therapeutic interventions.

Methods: We studied 299 metabolites in relation to cognition (general cognitive ability) in two discovery cohorts (N total = 5658). Metabolites significantly associated with cognition after adjusting for multiple testing were replicated in four independent cohorts (N total = 6652), and the associations with dementia and Alzheimer's disease (N = 25,872) and lifestyle factors (N = 5168) were examined.

Results: We discovered and replicated 15 metabolites associated with cognition including subfractions of high-density lipoprotein, docosahexaenoic acid, ornithine, glutamine, and glycoprotein acetyls. These associations were independent of classical risk factors including high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, glucose, and apolipoprotein E (APOE) genotypes. Six of the cognition-associated metabolites were related to the risk of dementia and lifestyle factors.

Discussion: Circulating metabolites were consistently associated with cognition, dementia, and lifestyle factors, opening new avenues for prevention of cognitive decline and dementia.

Keywords: Alzheimer's disease; Cognitive function; Dementia; General cognitive ability; Lifestyle factors; Metabolites; Metabolomics; NMR.

PubMed Disclaimer

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies

Affiliations

Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies

Authors

Affiliations

Erratum in

Abstract

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous